WMT

122.83

+1.99%↑

COST

978.2

+1.29%↑

PG

143.93

+0.08%↑

KO

75.3

+0.11%↑

PM

165.64

+1.1%↑

WMT

122.83

+1.99%↑

COST

978.2

+1.29%↑

PG

143.93

+0.08%↑

KO

75.3

+0.11%↑

PM

165.64

+1.1%↑

WMT

122.83

+1.99%↑

COST

978.2

+1.29%↑

PG

143.93

+0.08%↑

KO

75.3

+0.11%↑

PM

165.64

+1.1%↑

WMT

122.83

+1.99%↑

COST

978.2

+1.29%↑

PG

143.93

+0.08%↑

KO

75.3

+0.11%↑

PM

165.64

+1.1%↑

WMT

122.83

+1.99%↑

COST

978.2

+1.29%↑

PG

143.93

+0.08%↑

KO

75.3

+0.11%↑

PM

165.64

+1.1%↑

Search

Sysco Corp

Avatud

SektorTarbekaubad (kaitseaktsiad)

82.59 0.68

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

80.72

Max

82.82

Põhinäitajad

By Trading Economics

Sissetulek

-87M

389M

Müük

-386M

21B

P/E

Sektori keskmine

22.782

28.772

Aktsiakasum

0.99

Dividenditootlus

2.49

Kasumimarginaal

1.874

Töötajad

75,000

EBITDA

-119M

923M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+13.23% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.49%

3.67%

Järgmine tulemuste avaldamine

28. apr 2026

Järgmine dividendimakse kuupäev

24. apr 2026

Järgmine aktsia dividendi kuupäev (ex-date)

2. apr 2026

Turustatistika

By TradingEconomics

Turukapital

4.3B

40B

Eelmine avamishind

81.91

Eelmine sulgemishind

82.59

Uudiste sentiment

By Acuity

82%

18%

117 / 131 Pingereas Consumer defensive

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Sysco Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Sysco Corp Prognoos

Hinnasiht

By TipRanks

13.23% tõus

12 kuu keskmine prognoos

Keskmine 92.09 USD  13.23%

Kõrge 102 USD

Madal 83 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Sysco Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

13 ratings

8

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

70.06 / 72.54Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

117 / 131 Pingereas Tarbekaubad (kaitseaktsiad)

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Sysco Corp

Sysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. The company operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. It distributes frozen food, such as meat, seafood, fully prepared entrées, fruits, vegetables, and desserts; canned and dry food products; fresh meat and seafood products; dairy products; beverages; imported specialties; and fresh produce products. The company also supplies various non-food items, including paper products comprising disposable napkins, plates, and cups; tableware consisting of glassware and silverware; cookware, such as pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. It serves restaurants, hospitals and nursing facilities, schools and colleges, hotels and motels, industrial caterers, and other foodservice venues. The company was incorporated in 1969 and is headquartered in Houston, Texas.
help-icon Live chat